HSF1 and colorectal carcinoma: Therefore, colorectal cancer stage progression is likely to be correlated with the expression of HSF-1, which indicates that HSF-1 may be a useful biomarker for CRC prognosis and the development of novel therapeutic strategies for its treatment.